199 related articles for article (PubMed ID: 38565950)
1. LATS1 controls CTCF chromatin occupancy and hormonal response of 3D-grown breast cancer cells.
Ramírez-Cuéllar J; Ferrari R; Sanz RT; Valverde-Santiago M; García-García J; Nacht AS; Castillo D; Le Dily F; Neguembor MV; Malatesta M; Bonnin S; Marti-Renom MA; Beato M; Vicent GP
EMBO J; 2024 May; 43(9):1770-1798. PubMed ID: 38565950
[TBL] [Abstract][Full Text] [Related]
2. Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains.
Khoury A; Achinger-Kawecka J; Bert SA; Smith GC; French HJ; Luu PL; Peters TJ; Du Q; Parry AJ; Valdes-Mora F; Taberlay PC; Stirzaker C; Statham AL; Clark SJ
Nat Commun; 2020 Jan; 11(1):54. PubMed ID: 31911579
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer.
Achinger-Kawecka J; Valdes-Mora F; Luu PL; Giles KA; Caldon CE; Qu W; Nair S; Soto S; Locke WJ; Yeo-Teh NS; Gould CM; Du Q; Smith GC; Ramos IR; Fernandez KF; Hoon DS; Gee JMW; Stirzaker C; Clark SJ
Nat Commun; 2020 Jan; 11(1):320. PubMed ID: 31949157
[TBL] [Abstract][Full Text] [Related]
4. CTCF maintains regulatory homeostasis of cancer pathways.
Aitken SJ; Ibarra-Soria X; Kentepozidou E; Flicek P; Feig C; Marioni JC; Odom DT
Genome Biol; 2018 Aug; 19(1):106. PubMed ID: 30086769
[TBL] [Abstract][Full Text] [Related]
5. CTCF-Mediated Chromatin Loops between Promoter and Gene Body Regulate Alternative Splicing across Individuals.
Ruiz-Velasco M; Kumar M; Lai MC; Bhat P; Solis-Pinson AB; Reyes A; Kleinsorg S; Noh KM; Gibson TJ; Zaugg JB
Cell Syst; 2017 Dec; 5(6):628-637.e6. PubMed ID: 29199022
[TBL] [Abstract][Full Text] [Related]
6. Hi-C profiling of cancer spheroids identifies 3D-growth-specific chromatin interactions in breast cancer endocrine resistance.
Li J; Fang K; Choppavarapu L; Yang K; Yang Y; Wang J; Cao R; Jatoi I; Jin VX
Clin Epigenetics; 2021 Sep; 13(1):175. PubMed ID: 34535185
[TBL] [Abstract][Full Text] [Related]
7. CTCF mediates chromatin looping via N-terminal domain-dependent cohesin retention.
Pugacheva EM; Kubo N; Loukinov D; Tajmul M; Kang S; Kovalchuk AL; Strunnikov AV; Zentner GE; Ren B; Lobanenkov VV
Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2020-2031. PubMed ID: 31937660
[TBL] [Abstract][Full Text] [Related]
8. A tour of 3D genome with a focus on CTCF.
Wang DC; Wang W; Zhang L; Wang X
Semin Cell Dev Biol; 2019 Jun; 90():4-11. PubMed ID: 30031214
[TBL] [Abstract][Full Text] [Related]
9. Key role for CTCF in establishing chromatin structure in human embryos.
Chen X; Ke Y; Wu K; Zhao H; Sun Y; Gao L; Liu Z; Zhang J; Tao W; Hou Z; Liu H; Liu J; Chen ZJ
Nature; 2019 Dec; 576(7786):306-310. PubMed ID: 31801998
[TBL] [Abstract][Full Text] [Related]
10. A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations.
Zaurin R; Ferrari R; Nacht AS; Carbonell J; Le Dily F; Font-Mateu J; de Llobet Cucalon LI; Vidal E; Lioutas A; Beato M; Vicent GP
Nucleic Acids Res; 2021 Dec; 49(22):12716-12731. PubMed ID: 34850111
[TBL] [Abstract][Full Text] [Related]
11. CHD4 Conceals Aberrant CTCF-Binding Sites at TAD Interiors by Regulating Chromatin Accessibility in Mouse Embryonic Stem Cells.
Han S; Lee H; Lee AJ; Kim SK; Jung I; Koh GY; Kim TK; Lee D
Mol Cells; 2021 Nov; 44(11):805-829. PubMed ID: 34764232
[TBL] [Abstract][Full Text] [Related]
12. CTCF modulates allele-specific sub-TAD organization and imprinted gene activity at the mouse Dlk1-Dio3 and Igf2-H19 domains.
Llères D; Moindrot B; Pathak R; Piras V; Matelot M; Pignard B; Marchand A; Poncelet M; Perrin A; Tellier V; Feil R; Noordermeer D
Genome Biol; 2019 Dec; 20(1):272. PubMed ID: 31831055
[TBL] [Abstract][Full Text] [Related]
13. The ChAHP Complex Counteracts Chromatin Looping at CTCF Sites that Emerged from SINE Expansions in Mouse.
Kaaij LJT; Mohn F; van der Weide RH; de Wit E; Bühler M
Cell; 2019 Sep; 178(6):1437-1451.e14. PubMed ID: 31491387
[TBL] [Abstract][Full Text] [Related]
14. Multiple CTCF sites cooperate with each other to maintain a TAD for enhancer-promoter interaction in the β-globin locus.
Kang J; Kim YW; Park S; Kang Y; Kim A
FASEB J; 2021 Aug; 35(8):e21768. PubMed ID: 34245617
[TBL] [Abstract][Full Text] [Related]
15. Clustered CTCF binding is an evolutionary mechanism to maintain topologically associating domains.
Kentepozidou E; Aitken SJ; Feig C; Stefflova K; Ibarra-Soria X; Odom DT; Roller M; Flicek P
Genome Biol; 2020 Jan; 21(1):5. PubMed ID: 31910870
[TBL] [Abstract][Full Text] [Related]
16. Tales from topographic oceans: topologically associated domains and cancer.
Campbell MJ
Endocr Relat Cancer; 2019 Nov; 26(11):R611-R626. PubMed ID: 31505466
[TBL] [Abstract][Full Text] [Related]
17. Making sense of the linear genome, gene function and TADs.
Long HS; Greenaway S; Powell G; Mallon AM; Lindgren CM; Simon MM
Epigenetics Chromatin; 2022 Jan; 15(1):4. PubMed ID: 35090532
[TBL] [Abstract][Full Text] [Related]
18. Impact of 3D genome organization, guided by cohesin and CTCF looping, on sex-biased chromatin interactions and gene expression in mouse liver.
Matthews BJ; Waxman DJ
Epigenetics Chromatin; 2020 Jul; 13(1):30. PubMed ID: 32680543
[TBL] [Abstract][Full Text] [Related]
19. 3D chromatin remodeling potentiates transcriptional programs driving cell invasion.
Lebeau B; Jangal M; Zhao T; Wong CK; Wong N; Cañedo EC; Hébert S; Aguilar-Mahecha A; Chabot C; Buchanan M; Catterall R; McCaffrey L; Deblois G; Kleinman C; Park M; Basik M; Witcher M
Proc Natl Acad Sci U S A; 2022 Sep; 119(36):e2203452119. PubMed ID: 36037342
[TBL] [Abstract][Full Text] [Related]
20. LATS kinase-mediated CTCF phosphorylation and selective loss of genomic binding.
Luo H; Yu Q; Liu Y; Tang M; Liang M; Zhang D; Xiao TS; Wu L; Tan M; Ruan Y; Bungert J; Lu J
Sci Adv; 2020 Feb; 6(8):eaaw4651. PubMed ID: 32128389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
